WO2025169150 - CRYSTALLINE FORMS, CRYSTALLINE SALT FORMS, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME
National phase entry is expected:
Publication Number
WO/2025/169150
Publication Date
14.08.2025
International Application No.
PCT/IB2025/051335
International Filing Date
07.02.2025
Title **
[English]
CRYSTALLINE FORMS, CRYSTALLINE SALT FORMS, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME
[French]
FORMES CRISTALLINES, FORMES DE SEL CRISTALLIN, COMPOSITIONS LES CONTENANT ET LEURS MÉTHODES D'UTILISATION
Applicants **
REPARE THERAPEUTICS INC.
Inventors
DOVLETOGLOU, Angelos
LIVINGSTON, Robert Charles
XUE, Song
LI, Dansu
MILLER, Kimberly
Priority Data
63/551,592
09.02.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 9820 | |
| EPO | Filing, Examination, Granting | 168058 | |
| Japan | Filing, Examination, Granting | 5059 | |
| South Korea | Filing, Examination, Granting | 10821 | |
| USA | Filing, Examination, Granting | 57290 |
Total:
251,048
Contact Us
Abstract[English]
Disclosed are crystalline forms of (S)-Compound 1 and crystalline forms of (R)-Compound 1. (1-S) (1-R) as well as pharmaceutically acceptable salts, solvates, or hydrates thereof, useful for the treatment of a disease or condition, e.g., cancer.[French]
L'invention divulgue des formes cristallines de (S)-Composé 1 et des formes cristallines de (R)-Composé 1. (1-S) (1-R) ainsi que des sels, des solvates ou des hydrates pharmaceutiquement acceptables de ceux-ci, utiles pour le traitement d'une maladie ou d'une affection, par exemple le cancer.